Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy


Shouval D., Lai C., Chang T., Cheinquer H., Martin P., Carosi G., ...Daha Fazla

JOURNAL OF HEPATOLOGY, cilt.50, sa.2, ss.289-295, 2009 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Konu: 2
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1016/j.jhep.2008.10.017
  • Dergi Adı: JOURNAL OF HEPATOLOGY
  • Sayfa Sayıları: ss.289-295

Özet

Background/Aims: To evaluate the off-treatment durability of response in HBeAg-negative chronic hepatitis B patients who achieved a protocol-defined 'Response' (HBV-DNA < 0.7 MEq/mL and ALT < 1.25 x ULN) with entecavir at 48 weeks and the efficacy of entecavir in patients treated beyond one year.